SlideShare a Scribd company logo
1 of 18
Biomedical Research 2013
Rowan Daiksel
Dr. Torres-Muñoz
Experimental Design
Scientific Background
Hypothesis
Aims (Primary and Secondary)
Materials
Methods (Protocols)
Expected Results
Results
Statistical Analyses
Reports:
Aims
• Become familiar with cancer research
• To learn about Circulating Tumor Cells (CTC’s)
• Methods to analyze them:
• Microfiltration
• Immunofluorescence (IF)
• Antigen determinants that identify them as CTC
• Quantitation of antigen determinant in CTC
Aims
• Become familiar with experimental design
• Controls :
• Biological
• Experimental
• Learn how to culture cancer cells
• Thawing
• Culturing
• Splitting
• Freezing
Thawing
Cell Culturing
After 24 hours After 48 hours
After 72
hours
Cell Splitting
Split Cells into two
25 mL flasks
Cell Freezing
Fixing for Immunofluorescence
Other Names for
Formaldehyde:
IUPAC Name: Methanal
Methyl aldehyde
Methyl glycol
Methylene oxide
Formalin
Formol
Immunofluorescence (IF)
Secondary Anti-Rabbit
Antibody (raised in
goat)
Anti-Cytokeratin
(rabbit)
Blocked with goat
serum
Results from
Immunofluorescence
Negative ControlWith Primary and
Secondary Ab
Cytokeratin DAPI
Both CK & DAPI
Double Staining IF
Anti- CK Ab
(Rabbit)
Secondary
Anti-Rabbit
Ab (goat)
Anti-CD44
MAb
(mouse)
Anti-mouse
Ab (goat)
Blocked with
Goat Serum
IF: A431 CK-A594/CD44-A488/DAPI
C. CD44-A488/DAPI
CK-A594/ CD44-A488/DAPI CK-A594/ DAPI
DAPI
Double Staining Quantitation
A431 DAPI
CD44 A488A431 CK A595
A431 CK A594 CD44 A488 DAPI Merge
Laser Capture Micro-dissection
(LCM)
Thank You
Dr. Torres-Muñoz
Dr. Cote
Dr. Datar

More Related Content

What's hot

Cryo 2014 CellSeal Presentation - Final without video
Cryo 2014 CellSeal Presentation - Final without videoCryo 2014 CellSeal Presentation - Final without video
Cryo 2014 CellSeal Presentation - Final without video
Evonne R. Fearnot, MSBME
 
Drug discoverydevelopment
Drug discoverydevelopmentDrug discoverydevelopment
Drug discoverydevelopment
Lokesh ML
 
High throughput screening (hts) copy
High throughput screening (hts)   copyHigh throughput screening (hts)   copy
High throughput screening (hts) copy
Iqrar Ansari
 
Development mol drug
Development mol drugDevelopment mol drug
Development mol drug
swati2084
 
Biotechnology And Chemical Weapons Control
Biotechnology And Chemical Weapons ControlBiotechnology And Chemical Weapons Control
Biotechnology And Chemical Weapons Control
guest971b1073
 

What's hot (20)

MDC Connects: Targeted compound libraries
MDC Connects: Targeted compound librariesMDC Connects: Targeted compound libraries
MDC Connects: Targeted compound libraries
 
MDC Connects: Biomarker identification - Assessing Immune Function
MDC Connects: Biomarker identification - Assessing Immune FunctionMDC Connects: Biomarker identification - Assessing Immune Function
MDC Connects: Biomarker identification - Assessing Immune Function
 
Reverse pharmacognosy
Reverse pharmacognosyReverse pharmacognosy
Reverse pharmacognosy
 
MDC Connects: Designing a Biomarker Strategy
MDC Connects: Designing a Biomarker StrategyMDC Connects: Designing a Biomarker Strategy
MDC Connects: Designing a Biomarker Strategy
 
Cryo 2014 CellSeal Presentation - Final without video
Cryo 2014 CellSeal Presentation - Final without videoCryo 2014 CellSeal Presentation - Final without video
Cryo 2014 CellSeal Presentation - Final without video
 
Drug discoverydevelopment
Drug discoverydevelopmentDrug discoverydevelopment
Drug discoverydevelopment
 
Antibodies for Immunohistochemistry (IHC)
Antibodies for Immunohistochemistry (IHC)Antibodies for Immunohistochemistry (IHC)
Antibodies for Immunohistochemistry (IHC)
 
High School Career Day Drug Development 2010
High School Career Day Drug Development 2010High School Career Day Drug Development 2010
High School Career Day Drug Development 2010
 
DRUG discovery
DRUG discoveryDRUG discovery
DRUG discovery
 
High throughput screening (hts) copy
High throughput screening (hts)   copyHigh throughput screening (hts)   copy
High throughput screening (hts) copy
 
Drug discovery and development
Drug discovery and developmentDrug discovery and development
Drug discovery and development
 
Ifpma - Points to consider - biotherapeutics vs small molecule medicines - Wo...
Ifpma - Points to consider - biotherapeutics vs small molecule medicines - Wo...Ifpma - Points to consider - biotherapeutics vs small molecule medicines - Wo...
Ifpma - Points to consider - biotherapeutics vs small molecule medicines - Wo...
 
GENOTOXICITY STUDIES(as per OECD)
GENOTOXICITY STUDIES(as per OECD)GENOTOXICITY STUDIES(as per OECD)
GENOTOXICITY STUDIES(as per OECD)
 
In-Vivo Safety - Pre Ind Drug Development
In-Vivo Safety - Pre Ind Drug DevelopmentIn-Vivo Safety - Pre Ind Drug Development
In-Vivo Safety - Pre Ind Drug Development
 
Development mol drug
Development mol drugDevelopment mol drug
Development mol drug
 
Biometrics services offered by cro’s
Biometrics services offered by cro’sBiometrics services offered by cro’s
Biometrics services offered by cro’s
 
drug discovery & development
drug discovery & developmentdrug discovery & development
drug discovery & development
 
Richard Duke Basics of Drug Discovery and Development
Richard Duke Basics of Drug Discovery and DevelopmentRichard Duke Basics of Drug Discovery and Development
Richard Duke Basics of Drug Discovery and Development
 
Use of Microorganisms, Animals, Plants and Humans in Experimentation
Use of Microorganisms, Animals, Plants and Humans in ExperimentationUse of Microorganisms, Animals, Plants and Humans in Experimentation
Use of Microorganisms, Animals, Plants and Humans in Experimentation
 
Biotechnology And Chemical Weapons Control
Biotechnology And Chemical Weapons ControlBiotechnology And Chemical Weapons Control
Biotechnology And Chemical Weapons Control
 

Similar to Research Presentation 1 17-53-18-176

2013-11-26 DTL FIH symposium, Leiden
2013-11-26 DTL FIH symposium, Leiden2013-11-26 DTL FIH symposium, Leiden
2013-11-26 DTL FIH symposium, Leiden
Alain van Gool
 
EHR-based Phenome Wide Association Study in Pancreatic Cancer
EHR-based Phenome Wide Association Study in Pancreatic CancerEHR-based Phenome Wide Association Study in Pancreatic Cancer
EHR-based Phenome Wide Association Study in Pancreatic Cancer
Tomasz Adamusiak
 
Discovering New Innovations in Oncology
Discovering New Innovations in OncologyDiscovering New Innovations in Oncology
Discovering New Innovations in Oncology
InsideScientific
 
ELAD study vti 208 - Maimonides Team Brooklyn Dinner - March 4 2014
ELAD study vti 208  - Maimonides Team Brooklyn Dinner - March 4 2014ELAD study vti 208  - Maimonides Team Brooklyn Dinner - March 4 2014
ELAD study vti 208 - Maimonides Team Brooklyn Dinner - March 4 2014
Dr. Lewis Teperman
 
Using Multi-Scale Modeling to Support Preclinical Developments
Using Multi-Scale Modeling to Support Preclinical DevelopmentsUsing Multi-Scale Modeling to Support Preclinical Developments
Using Multi-Scale Modeling to Support Preclinical Developments
Tao You
 

Similar to Research Presentation 1 17-53-18-176 (20)

2013-11-26 DTL FIH symposium, Leiden
2013-11-26 DTL FIH symposium, Leiden2013-11-26 DTL FIH symposium, Leiden
2013-11-26 DTL FIH symposium, Leiden
 
Liverpool uemseflm2014
Liverpool uemseflm2014Liverpool uemseflm2014
Liverpool uemseflm2014
 
EHR-based Phenome Wide Association Study in Pancreatic Cancer
EHR-based Phenome Wide Association Study in Pancreatic CancerEHR-based Phenome Wide Association Study in Pancreatic Cancer
EHR-based Phenome Wide Association Study in Pancreatic Cancer
 
2013-10-23 DTL Next Generation Life Sciences Event, Utrecht
2013-10-23 DTL Next Generation Life Sciences Event, Utrecht2013-10-23 DTL Next Generation Life Sciences Event, Utrecht
2013-10-23 DTL Next Generation Life Sciences Event, Utrecht
 
Advances in stem cell technology
Advances in stem cell technologyAdvances in stem cell technology
Advances in stem cell technology
 
Discovering New Innovations in Oncology
Discovering New Innovations in OncologyDiscovering New Innovations in Oncology
Discovering New Innovations in Oncology
 
Overcome the challenges of Nucleic acid isolation from PCR inhibitor-rich mic...
Overcome the challenges of Nucleic acid isolation from PCR inhibitor-rich mic...Overcome the challenges of Nucleic acid isolation from PCR inhibitor-rich mic...
Overcome the challenges of Nucleic acid isolation from PCR inhibitor-rich mic...
 
ELAD study vti 208 - Maimonides Team Brooklyn Dinner - March 4 2014
ELAD study vti 208  - Maimonides Team Brooklyn Dinner - March 4 2014ELAD study vti 208  - Maimonides Team Brooklyn Dinner - March 4 2014
ELAD study vti 208 - Maimonides Team Brooklyn Dinner - March 4 2014
 
MRCT's Centre for Therapeutics Discovery
MRCT's Centre for Therapeutics DiscoveryMRCT's Centre for Therapeutics Discovery
MRCT's Centre for Therapeutics Discovery
 
Introduction to Bioprocessing Sample Slides
Introduction to Bioprocessing Sample SlidesIntroduction to Bioprocessing Sample Slides
Introduction to Bioprocessing Sample Slides
 
Nw biotech fundamentals day 1 session 4 trends and techniques
Nw biotech fundamentals day 1 session 4   trends and techniquesNw biotech fundamentals day 1 session 4   trends and techniques
Nw biotech fundamentals day 1 session 4 trends and techniques
 
Cell Engineering and Molecular Pharming in Biopharmaceuticals.pptx
Cell Engineering and Molecular Pharming in Biopharmaceuticals.pptxCell Engineering and Molecular Pharming in Biopharmaceuticals.pptx
Cell Engineering and Molecular Pharming in Biopharmaceuticals.pptx
 
2013 10 23_dna_for_dummies_v_presented
2013 10 23_dna_for_dummies_v_presented2013 10 23_dna_for_dummies_v_presented
2013 10 23_dna_for_dummies_v_presented
 
Using Multi-Scale Modeling to Support Preclinical Developments
Using Multi-Scale Modeling to Support Preclinical DevelopmentsUsing Multi-Scale Modeling to Support Preclinical Developments
Using Multi-Scale Modeling to Support Preclinical Developments
 
Evaluation of hepatoprotective agents - Hemant Kanase
Evaluation of hepatoprotective agents - Hemant KanaseEvaluation of hepatoprotective agents - Hemant Kanase
Evaluation of hepatoprotective agents - Hemant Kanase
 
2014 12-11 Skipr99 masterclass Arnhem
2014 12-11 Skipr99 masterclass Arnhem2014 12-11 Skipr99 masterclass Arnhem
2014 12-11 Skipr99 masterclass Arnhem
 
Biotech chapter 1
Biotech chapter 1Biotech chapter 1
Biotech chapter 1
 
pk pd of antibiotics.pptx
pk pd of antibiotics.pptxpk pd of antibiotics.pptx
pk pd of antibiotics.pptx
 
Animal Cell Culture.pptx
Animal Cell Culture.pptxAnimal Cell Culture.pptx
Animal Cell Culture.pptx
 
Cell centered database for immunology and cancer research feb252016
Cell centered database for immunology and cancer research feb252016Cell centered database for immunology and cancer research feb252016
Cell centered database for immunology and cancer research feb252016
 

Research Presentation 1 17-53-18-176